Outlook Therapeutics, Inc. ($OTLK)
Filing Information
| Accession Number | 0000899140-26-000894 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
5,050,504
Total Value
$2,499,999.48
P&L
+26.5% (+$663,131.18)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 12, 2026 | Purchase | 2,525,252 | $0.99 | $2,499,999.48 | 24,617,320 | Indirect | See footnote | View Details | |
Director | Warrants (right to buy) | Derivative | Aug 12, 2026 | Purchase | 2,525,252 | $0.00 | $0.00 | 2,525,252 | Indirect | See footnote | View Details |